![Enno Spillner](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Enno Spillner
Financieel Directeur/CFO bij
FORMYCON AG
Vermogen: 146 800 $ op 30-06-2026
Profiel
Momenteel bekleedt Enno Spillner de functie van Chief Financial Officer voor Evotec SE en Co-Managing Director bij Evotec International GmbH (een dochteronderneming van Evotec SE). Hij is ook lid van de raad van bestuur van Nanobiotix SA en Concentro Management AG en Managing Partner bij Biom Venture Capital GmbH & Co. Fonds KG. In zijn vorige carrière was de heer Spillner Chief Executive & Financial Officer van 4SC AG, Managing Director bij Munich Innovative Biomaterials GmbH, Managing Director bij ActiPac Biosystems GmbH en Head-Finance & Controlling bij BioM AG Munich BioTech Development. Enno Spillner behaalde een MBA aan de Universiteit van Bamberg.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
NANOBIOTIX SA 0,01% | 31-03-2026 | 4.000 ( 0,01% ) | 146 800 $ | 30-06-2026 |
Actieve functies van Enno Spillner
| Bedrijven | Functie | Begin |
|---|---|---|
| NANOBIOTIX | Directeur/Bestuurslid | 18-06-2014 |
| FORMYCON AG | Financieel Directeur/CFO | 01-04-2023 |
Concentro Management AG
 Concentro Management AG Investment ManagersFinance Provides financial consulting services | Directeur/Bestuurslid | 11-05-2010 |
leon-nanodrugs GmbH
 leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Directeur/Bestuurslid | - |
Euronext Paris SA
 Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Directeur/Bestuurslid | 01-01-2014 |
Eerdere bekende functies van Enno Spillner
| Bedrijven | Functie | Einde |
|---|---|---|
| EVOTEC SE | Financieel Directeur/CFO | 01-03-2023 |
| 4SC AG | Algemeen Directeur | 30-06-2016 |
ActiPac Biosystems GmbH | Algemeen Directeur | 01-03-2000 |
Munich Innovative Biomaterials GmbH
 Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Algemeen Directeur | - |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ ░░░░░░░░░ | - |
Opleiding van Enno Spillner
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
41
Eerstegraads connecties
13
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 13 |
|---|---|
4SC AG
 4SC AG BiotechnologyHealth Technology Develops drugs for cancer treatment | Health Technology |
Evotec SE
 Evotec SE Miscellaneous Commercial ServicesCommercial Services Provides drug discovery and development services | Commercial Services |
Evotec International GmbH
 Evotec International GmbH Miscellaneous Commercial ServicesCommercial Services Develops and provides drugs specializing in the treatment of CNS disorders | Commercial Services |
Euronext Paris SA
Euronext Paris SA Investment Banks/BrokersFinance Operates a stock exchange which provides solutions for regulated stock and derivatives markets in France | Finance |
BioM AG Munich BioTech Development
 BioM AG Munich BioTech Development Investment ManagersFinance BMBD is a venture capital investment manager specialized in early-stage biotechnology companies with high-growth potential. The firm invests in Europe with a strong focus on the Munich area. They generally co-invest, often in companies first launched through a seed investment from BioM. BMBD generally acquires minority stakes. Their goal is to accompany their portfolio companies into the later stages of development. In addition to capital, the firm provides business support services leveraging BioM's network and capabilities. | Finance |
University of Bamberg
 University of Bamberg Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biom Venture Capital GmbH & Co. Fonds KG
 Biom Venture Capital GmbH & Co. Fonds KG Investment ManagersFinance Acts as Venture Capital Fund | Finance |
Nanobiotix SA
 Nanobiotix SA Pharmaceuticals: MajorHealth Technology Develops and manufactures nanotherapeutics for treatment of cancer | Health Technology |
Concentro Management AG
Concentro Management AG Investment ManagersFinance Provides financial consulting services | Finance |
Formycon AG
 Formycon AG Pharmaceuticals: MajorHealth Technology Develops biopharmaceutical products | Health Technology |
leon-nanodrugs GmbH
leon-nanodrugs GmbH Information Technology ServicesTechnology Services Provides technology solutions for nanoparticle manufacturing | Technology Services |
ActiPac Biosystems GmbH | |
Munich Innovative Biomaterials GmbH
Munich Innovative Biomaterials GmbH Investment ManagersFinance Functions as a pension/retirement fund | Finance |
Kies MarketScreener 
